Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia
by Pfeifer, Heike (Author)
, Wassmann, B. (Author)
, Bethge, W. (Author)
, Dengler, Jolanta (Author)
, Bornhäuser, M. (Author)
, Stadler, M. (Author)
, Beelen, D. (Author)
, Vucinic, V. (Author)
, Burmeister, T. (Author)
, Stelljes, M. (Author)
, Faul, C. (Author)
, Dreger, Peter (Author)
, Kiani, A. (Author)
, Schäfer-Eckart, K. (Author)
, Schwerdtfeger, R. (Author)
, Lange, E. (Author)
, Kubuschok, B. (Author)
, Horst, H. A. (Author)
, Gramatzki, M. (Author)
, Brück, P. (Author)
, Serve, H. (Author)
, Hoelzer, D. (Author)
, Gökbuget, N. (Author)
, Ottmann, O. G. (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource